1. Calame, Daniel G, Guo, Tianyu, Wang, Chen, Gu, Shen, Lupski, James R. 2023. Monoallelic variation in DHX9, the gene encoding the DExH-box helicase DHX9, underlies neurodevelopment disorders and Charcot-Marie-Tooth disease. In American journal of human genetics, 110, 1394-1413. doi:10.1016/j.ajhg.2023.06.013. https://pubmed.ncbi.nlm.nih.gov/37467750/
2. Ren, Xingxing, Wang, Decai, Zhang, Guorong, Flavell, Richard A, Zhu, Shu. 2023. Nucleic DHX9 cooperates with STAT1 to transcribe interferon-stimulated genes. In Science advances, 9, eadd5005. doi:10.1126/sciadv.add5005. https://pubmed.ncbi.nlm.nih.gov/36735791/
3. Aktaş, Tuğçe, Avşar Ilık, İbrahim, Maticzka, Daniel, Backofen, Rolf, Akhtar, Asifa. 2017. DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome. In Nature, 544, 115-119. doi:10.1038/nature21715. https://pubmed.ncbi.nlm.nih.gov/28355180/
4. Lee, Teresa, Pelletier, Jerry. . The biology of DHX9 and its potential as a therapeutic target. In Oncotarget, 7, 42716-42739. doi:10.18632/oncotarget.8446. https://pubmed.ncbi.nlm.nih.gov/27034008/
5. Liu, Shenglan, He, Liangmei, Wu, Junhong, Xie, Fuhua, Liu, Zhiping. 2021. DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway. In Cellular and molecular life sciences : CMLS, 78, 8261-8281. doi:10.1007/s00018-021-04013-3. https://pubmed.ncbi.nlm.nih.gov/34773477/